FGFR4 and cardiac hypertrophy: Thus, both gain and loss of FGF21-FGFR4 signaling in mouse models, as well as in vitro studies using adult cardiac myocytes, suggest that elevated FGF21 signaling promotes pathological concentric cardiac hypertrophy.